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BRIC’s Growing Share in Global Wealth
Post-cold war developments and accelerated pace of globalization among many changes led to the
creation of so called emerging markets. These classical national economies represent few among
large number of developing world countries, which are distinguished by their exceptionally strong
promise of rapid and long-term stable growth of gross domestic product. Either we assess it on
nominal or purchase power parity (PPP) terms, four distinct economies obviously lay ahead all
other rapidly developing global markets. Acronym BRIC (Brazil, Russia, India, China) forged to
describe these countries brought glory to its creator Jim O’Neil, Goldman Sachs’ economist of
the time (1). Since his first insight back in 2001 global recession (2) and ongoing developments
were changing prospects for all four individual markets. Nevertheless, strong positive growth trend
remained their common feature although with quite substantial differences in pace and balance
of overall economy development (3). BRIC’s share in global wealth grew tremendously effectively
quadrupling itself over past decade (4). Joint growth of this group of countries, heavily dominated
by China, will remain long-term trend with clear forecasts at least up to the middle of twenty-first
century (5).
Consequences for National Health Systems of these Nations
Each one of BRICs countries enjoyed prolonged period of geopolitical stability. Local governments
via different mechanisms succeeded to use welfare of the society to improve access and quality
of health care (6). Rising middle classes contributed to the higher demand for pharmaceuticals
and novel medical technologies, particularly in developed urban cores. Long-term neglect of rural
populations, many of them living close to poverty line, finally led to more decisive polices to
tackle these issues. Health insurance coverage recorded its first serious improvements in these
regions (7). Affordability of medical care to ordinary citizens was spreading although not suffi-
ciently to follow-up disproportionate rapid growth of out of pocket spending (8). This effectively
meant some serious setbacks affecting health care access to the poor (9). Many of such issues
remain high on local health policy agendas and unresolved so far. Another important obstacle
in mammoth sized health sectors of these nations is delivery of cutting edge treatment options
to the citizens. Local innovation rate remains quite modest compared to huge research and
development investment particularly characteristic of People’s Republic of China (10). Promising
signs are rapidly growing frequency of scientific publications in medicine, technology patents,
and strengthening of local research capabilities in terms of human resources, institutional com-
mitment, and capital investment into equipment. Although similar positive changes are clear in
all four countries, China is once again surpassing all other BRIC members with its capacity and
output (11).
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Total Health Expenditures Among BRICs in
Nominal and Purchase Power Parity Terms
Global health expenditure database (GHED) relying on national
health accounts (NHA) system to track financial flows within
national health systems of all World Health Organization (WHO)
members across the globe was established since 1995 with lat-
est official release of 2012 data (12). This is probably the most
comprehensive single source allowing for international compara-
bility of data. Observing these 18 years we might come to terms
with many fine hidden patterns of health spending transforma-
tion that occurred worldwide and among the BRIC themselves.
Global share of BRIC nations in total health expenditure (THE)
grew from 4% ($108,938) to 12% ($858,193) in nominal terms
($USD) while change from 9% ($220,650) to 16% ($1,289,861)
was evenmore profound in PPP terms. Joint health expenditure by
BRIC nations succeeded to raise sixfold in less than two decades.
Calculations of global health spending refer to 193 countries or
political entities for whom complete records are available within
GHED registry. Most surprising evidence comes from internal
THE relationships among Brazil, India, Russian Federation, and
China (Figure 1). Back in 1995, THE composition of BRICs in
nominal terms was dominated by Brazil (31%) followed by China
(29%) and approximately equal shares of Russia and India of
20%. Recent 2012 data point out to entirely different nominal
THE landscape heavily dominated by China with 52%, followed
by Brazil (17%), Russia (16%), and India (15%) all three very
close to each other. THE expressed in $PPP reveals quite different
picture. In 1995, Brazil held even 47% of joint spending while it
FIGURE 1 | Long-term trend on total national – level expenditure on
health (THE) 1995–2012; Above: THE expressed in million current
international $PPP (purchase power parity value); Beneath: THE
expressed in million current US $ (nominal value); Source: Global
Health Expenditure Database.
was followed by China (24%), Russia (15%), and India (14%). If
we observe percentage of gross domestic product (GDP) spent
on health by individual countries it is easy to notice that only
India remained at 4% level. Each of other three countries gained
momentum of higher GDP proportion dedicated to health care
today compared to situation 20 years ago. Such capital investment
was led by Brazil (2.7% increase) followed by China (1.9) and
Russia (0.9).
Prospects of Retaining Long-Term Growth
in Health Spending Among the BRICs
All aforementioned data point out to the several important facts.
In the beginning of observation period, Brazil was dominating
the BRICs landscape both in terms of nominal and PPP and
percentage of gross domestic product health spending (13). Over
the course of years, Brazil remained on the lead only in terms of
last one (14). It is THE expressed as percentage of GDP reached
9.31% topping the list with both scale of increased and its absolute
value. India, regardless of huge increase in national welfare and
economic output decided to forcibly maintain its expenditure at
4% of GDP (15). Respective amount available for various health
programs became much larger anyway, so it recorded successes
in expanding health insurance coverage and access to medical
services (16). One important advantage of India compared to its
three remaining counterparts is far younger population due to
delayed population aging process in this large nation. Therefore,
the burden of major prosperity diseases and elderly age remains
significantly easier to cope with (17). Although India’s share in
BRIC’s joint THE fell significantly in percentage terms we should
not forget that scope of financial means disposable for health care
actually quadrupled in same period in both nominal and PPP
terms. Russian Federation recorded growth of THE in all terms
over past two decades but its share of BRIC’s joint THE remained
at the same level (18). Nevertheless, systemic health reforms and
overall economic performance were developing in the last BRIC’s
member faster than anywhere else (19). The BRIC’s composition
of THE observed as national level spending from year to year
becomes more and more dominated by China. This is still not
the case with per capita spending where Russia’s THE per capita
exceeds Chines three times ($1,474 PPP in 2012) and Brazilian
($1,109 PPP in 2012) more than twice. Many of microeconomic
indicators and identified health system weaknesses point out that
there is long ahead of Chinese health reforms (20). Regardless
of some setbacks global multinational industry of pharmaceuti-
cals and medicinal devices will target and support largest global
markets (21). The potential of all BRIC nations, led by People’s
Republic of China to absorb newmedical technologies and further
raise demand for medical goods and services will most likely
remain high in the long run (22).
BRIC’s vs. OECD’s Health Expenditures
Many forecasts actually point out to the growing competitiveness
of BRICs compared to major OECD markets. OECD’s joint share
of global health expenditure still far exceeds the one of BRICs
although OECD/BRICs ratio of joint THE fell from 22 times
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in nominal terms in 1995 to 7 times in 2012. This same ratio
expressed in PPP terms felt from ninefold larger THE in favor
of OECD in 1995 to only fourfold larger THE in 2012. OECD’s
proportion of global health spending fell from 91 to 81% in nom-
inal terms and from 82 to 72% in PPP terms. The global trend of
gains and losses in health spending clearly went in favor of largest
emerging markets at the expense of mature, traditional high-
income OECD economies (23). We should not forget that BRIC’s
growth alone is not sufficient to explain existing differences.
Significant part of these gains in national health budgets should
be attributed to smaller N-11 emerging markets, South Africa
and large number of middle- and low-income countries mostly
situated in Asia, Eastern Europe, Latin America, and Africa (24).
The global landscape of health care spending has clearly changed
more in recent past than for the most of twentieth century (25).
Beyond Tomorrow?
Health policymakers are aware they should stay precautious about
newly built socioeconomic welfare of many developing countries.
Their national capacities to direct investment and growing capac-
ities into the most rewarding, evidence based and cost-effective
medical procedures and drugs remain very limited. Knowledge-
based resource allocation still has to make roots in health policy
traditions of BRICs and other emerging nations (26). Health
outcomes offer final judgment on success of health care delivery
to the patients in needs. Longevity gains were indeed substantial
while fall in neonatal, maternal mortality, and incidence rates of
communicable diseases records continuous success in these coun-
tries (27). Nevertheless, life expectancy at birth and likelihood
of healthy aging remain by far higher in high-income economies
with Japan topping the list (28). Facing the upcoming burden of
accelerated population aging will be particularly challenging in
the emerging markets where such demographic transition was far
more rapid compared to most of developed societies. Official UN
forecasts tell us that China will be the fastest aging among large
nations for many upcoming decades (29). Very similar changes,
at slightly slower pace began happening much earlier in Russia
followed by Brazil. Morbidity structure of BRICs, with partial
exception of India, has already changed toward the one dom-
inated by non-communicable prosperity diseases. All of BRICs
share another important geographic determinant. They do have
very uneven population distributionwith exceptionally large rural
areas remote to most specialty hospitals and university clinics.
Development of rural network of medical facilities although tra-
ditionally stronger in Russia (30), presents particular challenge
to China, India, and Brazil (31). Lack of willingness in local
physicians and nurses to get employed in the country side far
away frommore attractive career prospects in large cities, presents
another obstacle leading to effective shortages of professional staff
(32). Common citizens inhabiting these areas usually earn less
income than those living in rich industrial cities (33). Vulner-
ability to catastrophic household expenditure due to illness of
family member is high (34). In line with these facts, out of pocket
expenditure grew tremendously in all of BRICs from $67 PPP
on average in 1995 to $276 PPP in 2012. Among several causes,
widespread informal payments remain significant cost driver for
ordinary people (35). Faced with so many ongoing challenges
it would be very hard to present any reliable future forecasts
for health care affordability and sustainable financing in BRICs
(36).Whether their impressive long-term efforts will bringworthy
fruits in population health will probably be fully visible in the
second half of twenty-first century.
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